Li He
Lawyers
Filters
BeiGene RMB22.2 billion Shanghai IPO
The offering, equivalent to $3.5 billion, is the largest biotech IPO to date in 2021
Yonghe HK$1.49 billion IPO
The shares are listed on the HKEX
Bilibili $1.6 billion sustainable convertible notes offering
The 0.5% convertible senior notes are due 2026
ANE HK$1.1 billion IPO
We advised ANE on its IPO and HKEX listing
Broncus Holding HK$1.55 billion IPO
We advised Broncus on its IPO and HKEX listing
Helens HK$2.51 billion IPO
We advised the underwriter on the IPO and HKEX listing
Kindstar Globalgene Technology HK$2.21 billion IPO
We advised Kindstar Global on its IPO and HKEX listing
Zylox-Tonbridge Medical Technology HK$2.56 billion IPO
We advised Zylox-Tonbridge Medical Technology on its IPO and HKEX listing
Nayuki Holdings HK$5.1 billion IPO
We advised Nayuki Holdings on its IPO and HKEX listing
Missfresh $273 million IPO
We advised the underwriters on the IPO and Nasdaq listing